热门资讯> 正文
BioLASE宣布从纳斯达克退市
2024-06-19 04:10
- BIOLASE (NASDAQ:BIOL) on Tuesday said it has received a notice from Nasdaq that it has determined to delist the shares of the company's common stock from Nasdaq Stock Market.
- The delisting is a result of failure to satisfy the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule and failure to comply with Nasdaq's $2,500,000 minimum stockholders' equity requirement for continued listing.
- Suspension of trading in the company's common stock on the Nasdaq exchange will be effective at the opening of trading on June 20, 2024.
- Source: Press Release
More on Biolase
- Seeking Alpha’s Quant Rating on Biolase
- Historical earnings data for Biolase
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。